Compounded tirzepatide
Sold by DoctorAdam · Oral tablet · every compounded tirzepatide record
What you actually pay
Per month
$199
| Medication · Tirzepatide Oral Tablets, from-price | $199 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Tirzepatide Oral Tablets, from-price “In stock From $199 Tirzepatide Oral Tablets Needle-free dual-action GLP-1/GIP support for appetite control.” source, read September 2, 2026 | Per month$199 | Charged today$199 |
We earn nothing from this link. DoctorAdam has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
- September 2, 2026 — $199
- September 3, 2026 — $199
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | Olympia Pharmaceuticals, Orlando FL; Carie Boyd Pharmaceuticals, Irving TX |
|---|---|
| States | 44 states: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, and Wyoming |
| Prescriber | Both |
| Membership | Not disclosed |
Not yet checked: cancellation and consult fee.
Recorded from doctoradam.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — Same FAQ page contains two contradictory state-coverage claims: one sentence says 'serving patients in 47 states and Washington, D.C., excluding NJ, MS, and AK,' while a separate, explicitly-enumerated 'We proudly serve the following states' list two lines later names only 44 states (also missing MA, RI, and VT). Recorded the explicit enumerated list per the register's rule to prefer a real list over a vague count, and flagged the contradiction here rather than reconciling it. No 'oral tirzepatide' category exists in this register's schema, so the Tirzepatide Oral Tablets product was recorded as compounded tirzepatide / oral-tablet. Cancellation was recorded as not found because the only relevant policy language found describes non-cancellable, non-refundable shipped orders, with no statement that an ongoing subscription itself can be canceled going forward.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.